Additional file 4 of Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker
Supplementary Material 4: The correlation between SCL16A3 expression and different clinical features in pan-cancer. (A-D) Tumor stage; (E-G) primary therapy treatment response; (H-J) histologic grade.
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|